Specialist Updates 
Cardiology

Early rhythm control reduces events in AF, trial shows

The results could change clinical practice, leading cardiologist says
Medicom Staff writer
0
3 September 2020
Save
Please login to bookmark Close

AusDoc brings you the latest news from the European Society of Cardiology Congress 2020.

Initiation of rhythm-control therapy is associated with a lower risk of cardiovascular events and deaths than usual care among patients with early atrial fibrillation (AF) and multiple risk factors, a trial shows.

The study, across 11 European countries, included patients with AF diagnosed a median 36 days prior to enrolment, the European Society of Cardiology virtual congress (ESC 2020) was told this week.

The Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST-AFNET 4) randomised 2800 patients with early AF and CV conditions (mean age 70) to early rhythm control or usual care.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .